Caregiver Support Programs

To improve treatment outcomes and overall quality of life is often the primary goal of any treatment plan for people with chronic or life-changing health conditions. Being associated with severe effects on the patient’s quality of life and high rates of nonadherence, treatment outcomes of these diseases heavily depends on the level and quality of support the patients get. Caregivers play a critical role in providing their sick family members with the required support in the form of physical, emotional and moral care.

According to Lloydet al. (2017), patients of such diseases as schizophreniathat require long-term treatment can experience a better quality of life with antipsychotic medications which tend to ameliorate some symptoms over time, though individual responses differ. There are those who will discontinue medication because of debilitating side effects or poor efficacy. In such cases, caregivers provide the much-needed support to ensure the patient follows through with the recommended and treatment plan as agreed upon by both the patient and the physician.

Caregiversupport programs are therefore crucial as they provide caregivers with the training, educational resources, and multiple tools they (carers) need to perform their role successfully.

References

Lloyd, J., Lloyd, H., Fitzpatrick, R. and Peters, M., 2017. Treatment outcomes in schizophrenia: qualitative study of the views of family carers. BMC Psychiatry17(1), p.266.

Read More

Payer Support Services

Scientific advances and changes in the regulatory environment continue to create more treatment options such as for cancers, whose costs in some cases are high. This means that among other things, there is increased funding pressure on the part of the patients who need and seek these treatments. Health systems that provide payer support services are therefore crucial in overcoming the challenge of therapy unaffordability and enhancing access to much-needed treatment. Leopold et al. (2017) point out the need to provide affordable care and access to effective pharmaceutical innovations, equally noting that this is a global challenge. As a way out, Leopold et al. (2017) suggest the need for dialogueabout the financial boundaries of covering pharmaceuticals. This entails implementing structured communications with all stakeholders about setting priorities and financial limitsin health care.

It’s crucial to involve key stakeholders such as patients and the roader public for these innovations to succeed (Arora et al. 2008). Notably, involving stakeholders tends to result in successful program design, early buy-in, and achievement of lasting support for the program (Arora et al. 2008). Working with payers to enhance patients’ outcomes through custom-made reimbursement solutions that ensure fast and sustainable access to their treatment is, therefore, the best approach in so far as payer support services are concerned.

References

Arora, R., Boehm, J., Chimento, L., Moldawer, L. and Tsien, C., 2008. Designing and Implementing Medicaid Disease and Care Management Programs: A User’s Guide. AHRQ Publication, (07), p.08.

Leopold, C., Morgan, S.G. and Wagner, A.K., 2017. A rapidly changing global medicines environment: How adaptable are funding decision-making systems?. Health Policy121(6), pp.637-643.

Tuckson, R.V., 2013. A role for payers: remarks on the use of data and analytics in support of preventive care. American journal of preventive medicine44(1), pp.S27-S29.

Read More